Compare Nuwellis Inc (NUWE) vs Payoneer Global Inc (PAYO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Payoneer Global Inc — how do they compare? Nuwellis Inc trades at $1.49 (market cap $522.76K), while Payoneer Global Inc trades at $7.08 (market cap $2.40B). The key difference: Payoneer Global Inc is far larger — about 4591× Nuwellis Inc's market cap, and Payoneer Global Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | PAYO | |
|---|---|---|
Market Cap | $522.76K | $2.40B |
Sector | Technology | Technology |
52-Week High | $220.50 | $7.17 |
52-Week Low | $1.42 | $4.27 |
Enterprise Value | -$1.29M | $2.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Payoneer Global Inc. (PAYO) trades at $7.10, down 0.14% on the day, with a neutral technical signal and mixed earnings history. The company reported Q2 2026 EPS of $0.02, missing estimates, but revenue grew 10% year-over-year. Analysts maintain a 60% buy rating with an $8.20 consensus target, while the pending acquisition by Nuvei for $7.40 per share dominates news, prompting legal scrutiny over fairness.
Outlook is clouded by acquisition uncertainty; upside exists if the deal price is raised, but execution risks and margin pressure persist. Investors face near-term volatility from merger developments, with fundamental growth in B2B payments offering long-term potential if the transaction fails.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →
